Streetbeat News

Equity Actions

AMTD

AMTD IDEA Group (NYSE:AMTD) has announced an extension of its existing share repurchase program until the end of Q1 2024. The program was previously announced on August 22, 2023, and updated on September 22, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:41 pm

FDEU

SPE

Special Opportunities Fund, Inc. (NYSE:SPE) has dismissed its lawsuit against the board of directors of First Trust Dynamic Europe Equity Income Fund (NYSE:FDEU) following stockholder approval of a transaction to eliminate the trading discount in FDEU's shares and rescission of the control-share bylaw. However, SPE condemns the board's decision to seat two incumbent trustees of FDEU without a quorum.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:37 pm

HKD

AMTD Digital Inc. (NYSE:HKD) has announced an extension of its existing share repurchase program until the end of Q1 2024. The program was previously announced on August 22, 2023, and updated on September 22, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:32 pm

BTCUSD

COIN

MSTR

Crypto-related stocks Coinbase Global Inc (COIN) and MicroStrategy Inc (MSTR) are trading higher as Bitcoin (BTC) continues to rise on spot ETF optimism. Bitcoin is up nearly 13% over the last 24 hours and more than 22% over the last week. Major U.S. financial firms including BlackRock have made changes to their pending applications for spot Bitcoin ETFs. Coinbase is set to release its Q3 financial results on Nov. 2, while MicroStrategy is due to report Q3 earnings on Nov. 1.

Portfolio Pulse from Adam Eckert

October 24, 2023 | 1:19 pm

APCX

AppTech Payments Corp. (NASDAQ:APCX) has announced a registered direct offering of approximately $3.5 million of its common stock and warrants to a single institutional investor. The combined purchase price for each share and associated warrant will be $2.10. The company will issue 1,666,667 shares of common stock and warrants to purchase up to the same number of shares at $2.74 per share. The offering is expected to close on October 26, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 1:10 pm

EIS

FEZ

UUP

The ongoing Israel-Hamas conflict has entered its 18th day, with France proposing an expanded international coalition against Hamas. The IDF is seeking information on hostages held by Hamas. The conflict has potential global economic implications, as warned by the World Bank president. Market reactions show a surge in global equities, with S&P 500 Index futures gaining 0.4%. The SPDR DJ Euro STOXX 50 ETF (FEZ) rose by 0.5%, while the iShares MSCI Israel ETF (EIS) declined by 0.5%. The Invesco DB USD Index Bullish Fund ETF (UUP) increased by 0.3%.

Portfolio Pulse from Piero Cingari

October 24, 2023 | 1:04 pm

IONQ

Shares of quantum computing company IonQ Inc are trading lower after the company announced that its co-founder and chief science officer Chris Monroe will step down from his role at the company to return to academic, research and policy pursuits at Duke University. IonQ shares are up approximately 266% since the start of the year, but were down 14.2% at the time of publication.

Portfolio Pulse from Adam Eckert

October 24, 2023 | 12:48 pm

GM

GM's CEO announced that the new Bolt will use LFP batteries, which will result in billions of dollars in capital savings compared to the previous EV plan.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 12:44 pm

MMTOF

NSANF

RNLSY

Mitsubishi Motors plans to invest up to €200 million in Renault's EV unit Ampere. This investment is part of Mitsubishi's mid-term management plan focusing on electric vehicle development. The company is also intensifying collaboration with Alliance members Renault and Nissan as part of their commitment to the electrification acceleration phase. Mitsubishi Motors aims to improve its EV development technology and expand its EV line-up through this initiative.

Portfolio Pulse from Nabaparna Bhattacharya

October 24, 2023 | 12:43 pm

INM

LIAN

RTX

Raytheon Technologies reported better-than-expected Q3 results, updated guidance, and announced a $10 billion accelerated share-repurchase program. InMed Pharmaceuticals revealed unique pharmacological effects of INM-901 in Alzheimer's disease in preclinical studies. LianBio entered into an agreement with Bristol Myers Squibb for Mavacamten in China and other Asian markets.

Portfolio Pulse from ryanfaloona@benzinga.com

October 24, 2023 | 12:41 pm